NFKB1 and acute myeloid leukemia: Research showing that inhibiting NF-κB expression with the chemical BMS-345541 changed the expression of genes essential for leukemogenesis in AML cells generated from patients clearly established the role of NF-κB in leukemogenesis [118,119].